✦ LIBER ✦

Consensus statement: Benefits versus risks of medical therapy for acromegaly

Book ID: 115684799
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 764 KB
Volume: 97
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(94)90327-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Canadian consensus guidelines on long-te

Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks

✍ A. ROSTOM; P. MOAYYEDI; R. HUNT; FOR THE CANADIAN ASSOCIATION OF GASTROENTEROLOG 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

ADJUVANT THERAPY FOR PATIENTS WITH COLON

ADJUVANT THERAPY FOR PATIENTS WITH COLON AND RECTAL CANCER: SUMMARY OF NIH CONSENSUS STATEMENT

✍ National Cancer Institute; the Office of Medical Applications of Research of the 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Coxibs Versus Combination NSAID and PPI

Coxibs Versus Combination NSAID and PPI Therapy for Chronic Pain: An Exploration of the Risks, Benefits, and Costs

✍ Hur, C. 📂 Article 📅 2006 🏛 Harvey Whitney Books Company 🌐 English ⚖ 127 KB

Risk–benefit analysis of adalimumab vers

Risk–benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease

✍ Edward V. Loftus Jr; Scott J. Johnson; Si-Tien Wang; Eric Wu; Parvez M. Mulani; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 1 views

Background: Adalimumab is indicated for the treatment of moderately to severely active Crohn's disease (CD). A systematic analysis of risks and benefits of adalimumab versus traditional non-biologic therapies for patients refractory to non-biologic therapy is lacking. Methods: A base-case analysis

Medical Management of Hyperglycemia in T

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

✍ Nathan, D. M.; Buse, J. B.; Davidson, M. B.; Ferrannini, E.; Holman, R. R.; Sher 📂 Article 📅 2008 🏛 American Diabetes Association 🌐 English ⚖ 188 KB

Risk and Benefit Analysis of Concurrent

Risk and Benefit Analysis of Concurrent Chemoradiation (CRT) Versus Radiation Therapy Alone (RT) for Cervical Cancer in Patients Age 60 and Older

✍ Dunn, E.F.; Gondi, V.; Shaverdian, N.; Bentzen, S.; Sklenar, K.; Petereit, D.; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB